JMP Securities analyst Roy Buchanan downgraded Gritstone bio (NASDAQ: GRTS) from Market Outperform to Market Perform.The analyst comments: "Limited benefit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE